Molecular targets for breast cancer therapy and prevention
- 1 May 2001
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (5) , 548-552
- https://doi.org/10.1038/87872
Abstract
The recent completion of the human genome sequence has raised great hopes for the discovery of new breast cancer therapies based on newly-discovered genes linked to breast cancer development and progression. Here we describe breast cancer therapies that have emerged from gene-based scientific efforts over the past 20 years and that are now approved for clinical testing or treatment.Keywords
This publication has 51 references indexed in Scilit:
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- High constant incidence in twins and other relatives of women with breast cancerNature Genetics, 2000
- ABC of breast diseases: Breast cancer---epidemiology, risk factors, and geneticsBMJ, 2000
- Developments in chemotherapy of breast cancerCancer, 2000
- Adjuvant Therapy for Breast CancerAnnual Review of Medicine, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Annual hazard rates of recurrence for breast cancer after primary therapy.Journal of Clinical Oncology, 1996
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- Single and combination nonhormonal chemotherapy in breast cancerCancer, 1972